Maturity-onset diabetes of the young type 3 (HNF1A-MODY), Maturity-onset diabetes of the young type 1 (HNF4A-MODY) research hub

Effects of semaglutide as add-on therapy to sulfonylurea on plasma glucose in individuals with HNF1A- and HNF4A-MODY – A Steno MODERN-MODY project (MM-SEMA)

This study looks at whether adding a weekly injection called semaglutide to standard diabetes tablets can help adults with a rare, inherited type of diabetes (MODY). Researchers want to see if it improves daily blood sugar levels and reduces highs and lows, measured using a wearable continuous glucose sensor.